IRIS Accounts Production v25.1.3.33 14948539 director 20.6.23 31.10.24 31.10.24 0 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 14948539 2023-06-19 14948539 2024-10-31 14948539 2023-06-20 2024-10-31 14948539 2023-06-19 14948539 ns15:EnglandWales 2023-06-20 2024-10-31 14948539 ns14:PoundSterling 2023-06-20 2024-10-31 14948539 ns10:Director1 2023-06-20 2024-10-31 14948539 ns10:PrivateLimitedCompanyLtd 2023-06-20 2024-10-31 14948539 ns10:SmallEntities 2023-06-20 2024-10-31 14948539 ns10:AuditExempt-NoAccountantsReport 2023-06-20 2024-10-31 14948539 ns10:SmallCompaniesRegimeForDirectorsReport 2023-06-20 2024-10-31 14948539 ns10:SmallCompaniesRegimeForAccounts 2023-06-20 2024-10-31 14948539 ns10:FullAccounts 2023-06-20 2024-10-31 14948539 ns10:EntityHasNeverTraded 2023-06-20 2024-10-31 14948539 ns10:RegisteredOffice 2023-06-20 2024-10-31 14948539 ns5:CurrentFinancialInstruments 2024-10-31 14948539 ns5:Non-currentFinancialInstruments 2024-10-31 14948539 ns5:ShareCapital 2024-10-31 14948539 ns5:RetainedEarningsAccumulatedLosses 2024-10-31 14948539 ns5:LeaseholdImprovements 2023-06-20 2024-10-31 14948539 ns5:PlantMachinery 2023-06-20 2024-10-31 14948539 ns5:FurnitureFittings 2023-06-20 2024-10-31 14948539 ns5:ComputerEquipment 2023-06-20 2024-10-31 14948539 ns5:LeaseholdImprovements 2024-10-31 14948539 ns5:PlantMachinery 2024-10-31 14948539 ns5:FurnitureFittings 2024-10-31 14948539 ns5:ComputerEquipment 2024-10-31 14948539 ns5:AdditionsToInvestments 2024-10-31 14948539 ns5:CostValuation 2024-10-31 14948539 ns5:Non-currentFinancialInstruments 2023-06-20 2024-10-31

REGISTERED NUMBER: 14948539 (England and Wales)

Unaudited Financial Statements

for the Period 20 June 2023 to 31 October 2024

for

ROC HEALTH HOLDINGS LIMITED

ROC HEALTH HOLDINGS LIMITED (REGISTERED NUMBER: 14948539)

Contents of the Financial Statements

for the Period 20 June 2023 to 31 October 2024

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

ROC HEALTH HOLDINGS LIMITED

Company Information

for the Period 20 June 2023 to 31 October 2024

| DIRECTOR: | C Romete

| REGISTERED OFFICE: | C/O Thrings Llp

| 6 Drakes Meadow

| Swindon

| England

| SN3 3LL

| REGISTERED NUMBER: | 14948539 (England and Wales)

ROC HEALTH HOLDINGS LIMITED (REGISTERED NUMBER: 14948539)

Balance Sheet

31 October 2024

| Notes | £ | £ |

| FIXED ASSETS

| Tangible assets | 4 | 349,357 |  |

| Investments | 5 | 901 |  |

350,258 |  |

| CURRENT ASSETS

| Cash at bank | 85,133 |  |  |

| CREDITORS

| Amounts falling due within one year | 6 | 232,259 |  |

| NET CURRENT LIABILITIES | (147,126 | ) |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 203,132 |  |

| CREDITORS

| Amounts falling due after more than one year | 7 | 250,000 |  |

| NET LIABILITIES | (46,868 | ) |

| CAPITAL AND RESERVES

| Called up share capital | 900 |  |

| Retained earnings | (47,768 | ) |

(46,868 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ROC HEALTH HOLDINGS LIMITED (REGISTERED NUMBER: 14948539)

Balance Sheet - continued

31 October 2024

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 June 2025 and were signed by:

C Romete - Director

ROC HEALTH HOLDINGS LIMITED (REGISTERED NUMBER: 14948539)

Notes to the Financial Statements

for the Period 20 June 2023 to 31 October 2024

1. | STATUTORY INFORMATION

| Roc Health Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Improvements to property | - | Straight line over 3 years

| Plant and machinery | - | Straight line over 4 years

| Fixtures and fittings | - | Straight line over 4 years

| Computer equipment | - | Straight line over 3 years

| Investments in subsidiaries

| Investments in subsidiary undertakings are recognised at cost.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Going concern

| These accounts have been prepared on the going concern basis, on the understanding that the directors and shareholders will continue to financially support the company.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was NIL.

ROC HEALTH HOLDINGS LIMITED (REGISTERED NUMBER: 14948539)

Notes to the Financial Statements - continued

for the Period 20 June 2023 to 31 October 2024

4. | TANGIBLE FIXED ASSETS

| Improvements |  | Fixtures |

| to |  | Plant and |  | and |  | Computer |

| property |  | machinery |  | fittings |  | equipment |  | Totals

£ | £ | £ | £ | £ |

| COST

| Additions | 694 |  | 302,315 |  | 31,994 |  | 14,354 |  | 349,357 |  |

| At 31 October 2024 | 694 |  | 302,315 |  | 31,994 |  | 14,354 |  | 349,357 |  |

| NET BOOK VALUE

| At 31 October 2024 | 694 |  | 302,315 |  | 31,994 |  | 14,354 |  | 349,357 |  |

5. | FIXED ASSET INVESTMENTS

| Shares in

| group

| undertakings

£ |

| COST

| Additions | 901 |  |

| At 31 October 2024 | 901 |  |

| NET BOOK VALUE

| At 31 October 2024 | 901 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Amounts owed to group undertakings | 230,358 |  |

| Other creditors | 1,901 |  |

232,259 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

£ |

| Bank loans | 250,000 |  |

| The Borrower shall furnish the following collateral in respect of the Loan on terms acceptable to the Borrower:

| 1. Floating charge with first priority over all assets of the Borrower and its affiliates; and

| 2. Pledge in 10% of the shares with a nominal value of GBP 250,000 each of the Borrower.

8. | ULTIMATE CONTROLLING PARTY

| The controlling party is C Romete.